癌症疫苗对消化系统癌症的进展:临床试验的系统分析
1Graduate School, Heilongjiang University of Chinese Medicine, Harbin, People's Republic of China.
Cancer management and research
|November 17, 2025
概括
癌症疫苗,特别是核酸和类型,通过增强免疫反应,显示出治疗消化系统癌症的前景. 需要进一步的研究来克服临床使用的平台特定挑战.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 消化系统癌症是全球主要的健康负担,传统治疗方法 (如手术和化疗) 的成功有限.
- 这些癌症的晚期需要新的治疗策略.
- 癌症疫苗是改善治疗结果的有希望的途径.
研究的目的:
- 审查癌症疫苗在治疗消化系统癌症方面的潜力.
- 探索各种癌症疫苗类型的临床应用前景.
- 确定疫苗开发在这个领域的挑战和未来方向.
主要方法:
- 对涉及针对消化系统癌症的癌症疫苗的临床试验进行系统审查.
- 基于设计,治疗目标,疗效和安全数据的试验选.
- 分析了165个符合条件的临床试验.
主要成果:
- 核酸和类疫苗是主要研究的类型,重点是结直肠和胰腺癌.
- 癌症疫苗在增强免疫反应和克服瘤抵抗方面表现出潜力.
- 有相当数量的临床试验 (165) 符合纳入标准.
结论:
- 核酸和类疫苗显示了对消化系统癌症的治疗潜力.
- 核酸疫苗提供了可扩展性,但面临着交付和激活的挑战;类疫苗更安全,但可能会引起较弱的反应.
- 优化特定平台的策略和设计未来的临床试验对于成功转化到临床实践至关重要.
相关概念视频
Cancer Vaccines
939
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
939
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Cancer Survival Analysis
634
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
634
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


